• StorEn’s batteries deliver superior performances at a lower cost
• Company’s exclusive vanadium flow battery technology is based on a rechargeable flow battery
• With its innovative vanadium flow battery tech as a backdrop, the company is in the process of a RegA offering with four different investment tiers

From the first all-vanadium flow battery created almost four decades ago, StorEn Technologies has developed a revolutionary vanadium flow battery technology that has potential to revolutionize the energy-storage space. StorEn’s batteries deliver superior performances at a lower cost; they also fulfill growing market demand for more efficient and cost-effective energy storage (https://ibn.fm/Cw1Z4). StorEn’s exclusive vanadium flow battery technology is based on a rechargeable flow battery that stores energy using the ability of vanadium to exist in solution in four different oxidation states. The company uses this unique property of vanadium to produce batteries with just one electroactive element instead of two, eliminating the possibility of metal cross-contamination. The company’s current design was patented in 1986 by the University of New South Wales in Australia, where the first known commercial example of the all-vanadium flow battery was created by Dr. Maria Skyllas-Kazacos and her team. StorEn’s technology has also been influenced by information and research conducted and reported by individuals such as P.A. Pissoort in the 1930s and NASA researchers A. Pelligri and P.M. Spaziante in the 1970s. StorEn’s batteries have proven ability to discharge fully at 100% without decaying and losing capacity, unlike lithium batteries. To consumers, this means that 100% of the battery’s initial capacity will be available throughout the lifetime of the battery, which is in excess of 25 years. Thus no oversizing is needed and no additional costs will be incurred to compensate from the capacity lost over time. Maintenance on StorEn batteries is also game changing. Because the battery management system alerts the user when service is needed, consumers no longer need to schedule regular maintenance. Finally, because vanadium flow batteries are just seeing development begin, improvements are certain to come. Examples of anticipated advancement could include new components such as new membranes. In addition, as the technology becomes more widespread, cost reductions and economies of scale from higher performance as well as volume manufacturing of batteries and components are likely. With its innovative vanadium flow battery tech as a backdrop, the company is in the process of a RegA offering with four different investment tiers; each tier offers a different discount and reward. (Click here for more information.) With a proprietary product that answers the call for long-lasting, 100% recyclable, safe and affordable energy storage, StorEn is in an ideal position to leverage its disruptive, patent-pending, all-vanadium flow battery technology in a growing market. Incubated at the Clean Energy Business Incubator Program (“CEBIP”) within Stony Brook University in New York, StorEn is building upon the strengths of vanadium flow batteries to revolutionize the world of residential and industrial energy storage. For more information, visit the company’s website at www.StorEn.tech. NOTE TO INVESTORS: The latest news and updates relating to StorEn Technologies are available in the company’s newsroom at https://ibn.fm/StorEn

• Lexaria Bioscience has completed a study conducted by Canada’s National Research Council for the use of its DehydraTECH IP with five drugs known to target the main protease associated with SARS-CoV-2 infection, including remdesivir
• The SARS-CoV-2 infection is the underlying force behind the COVID-19 pandemic that has killed millions of people during the past year and currently has begun trending toward a rising infection rate again
• DehydraTECH technology helps drugs gain better bioavailability through quick and effective introduction into patients’ bloodstreams using oral administration as opposed to injections
• The recent study results demonstrate that DehydraTECH-processed remdesivir, ebastine, bepridil, rupintrivir, and colchicine, did not create unwanted covalently-bonded new molecular entities (“NMEs”), or changes in chemical structure

Media outlets have been reporting a new rising trend in COVID-19 infections, signaling health policy concerns about the potential for significant new demands on the medical community and raising questions about the sociological implications in the United States shortly before the new school year opens (https://ibn.fm/bMAMO). Many people remain unvaccinated and for anyone who contracts any viral disease including common influenza, drug treatment options can be the difference between life and death. Pharmaceutical technology innovator Lexaria Bioscience (NASDAQ: LEXX) announced success in the latest developmental step that may help antiviral medicines used to treat COVID or HIV/AIDS reach the bloodstream more effectively than ever. Lexaria announced July 15 that its antiviral drug molecular characterization study performed by the National Research Council (“NRC”), Canada’s premier federally funded research organization, has successfully demonstrated that Lexaria’s trademarked DehydraTECH platform does not create a covalently bonded new molecular entity (“NME”) when used to process select antiviral drugs (https://ibn.fm/Z3fEV). The results confirmed that the drugs tested remained stable and did not undergo changes in chemical structure when processed with DehydraTECH.  This could preserve the ability of this drug delivery platform to qualify for accelerated regulatory filings with the Food and Drug Administration (“FDA”) in the United States plus regulators elsewhere in the world. DehydraTECH was tested in conjunction with market-available antiviral drugs remdesivir, ebastine, bepridil, rupintrivir and colchicine, which are being investigate for possible use against the SARS-CoV-2 virus. The virus’ aggressive spread has been the root cause of the pandemic that has sickened some 192 million people and killed more than 4 million of them worldwide during the past year (https://ibn.fm/AnH8V). The potential for more rapid market authorizations of DehydraTECH provides the potential for cost savings to the healthcare system to try to deliver antiviral drugs more effectively if it can be delivered via an oral capsule instead of by injection. “We are looking at repurposing some of these drugs, being able to take an antiviral drug that traditionally could only be administered, for example, by injection. We might be able to apply it in an oral form through a pill,” Lexaria CEO Chris Bunka told Investing News Network (https://ibn.fm/buyWB). Delivering the medications in the form of a pill instead of a shot could help governments or health insurance companies save billions of dollars in administration costs alone. In December, the company announced the current stage of R&D for drugs known to target the main protease associated with SARS-CoV-2 infection, using male Sprague-Dawley rats to quantify and compare total drug delivery into the rodent bloodstream to control formulations (https://ibn.fm/QyeoO). “We are excited to work with remdesivir, one of the world’s leading drugs currently in use for treatment of COVID-19, to learn whether DehydraTECH may also enhance drug delivery characteristics of NtRTI’s,” Bunka said at the time. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• American Cannabis Partners (“ACP”) is a Northern California-based organic cannabis cultivation company that has assimilated the strengths of Jamaica’s marijuana growing reputation to create a stable and distinctive brand
• The company primarily employs rigorously vetted Jamaicans experienced and knowledgeable in growing strains of product that recreate the Caribbean Island’s product for licensing and sales under ACP’s ZÜK brand
• The overall cannabis industry is growing rapidly in the United States, with an anticipated market valuation of $30 billion by 2025
• Ironically, it’s more difficult than ever to get Jamaica’s famed marijuana in the Caribbean because of pandemic-related factors plus a devastating hurricane and drought during the past year

California and Michigan are the new places for a Jamaican getaway — if your getaway plans include a little ganja. While 2021 has been a bit brutal for the Caribbean island nation’s famed but largely illegal marijuana market, sustainable Jamaican experience canna-business innovator American Cannabis Partners (“ACP”)  is replicating the growing, feeding, temperatures, harvesting, and curing processes of Jamaican techniques to create a product unlike any other grower’s in the United States. An important factor in all of this is ACP’s close personal and positive relationship with the nation and people of Jamaica; a deep awareness of needs and not just business numbers. American Cannabis Partners employs a staff that is 90 percent Jamaicans hand-picked through what the company describes as an extremely difficult vetting process requiring not only the correct U.S. immigration status but also at least 10 years of experience in Jamaican growing and processing, with knowledge of certain strains and their characteristics that help ACP to gain a definable advantage in the organically grown cannabis industry. ACP’s partners use proprietary soil as well as recreated Jamaican natural supplements and environments to produce a product with more yield, faster growth, higher THC levels and more pronounced terpenes than the industry standard. The company is based in Northern California’s Emerald Triangle and distributes its ZÜK brand proprietary strains to partner California distributors and its own Michigan retail location. About 80 percent of its product is supplied to licensees for manufacturing, distribution and retail. Jamaica has long been a destination for pot, reggae and Rastafarians but has officially maintained a “just say no” approach to the leafy green drug. Terpene tourists recognize that enforcement is spotty and that the country has made some small decriminalization efforts in recent years. But last year’s heavy hurricane season, followed by a scorching drought this year, along with COVID pandemic-induced increases in local consumption and declines in the number of marijuana farmers, have caused tens of thousands of dollars in losses and shortages of bud on the street (https://ibn.fm/xCahT). California and Michigan have state-legal marijuana industries for adult recreational use, providing a fertile field of opportunity for ACP’s profile of raw product in multiple forms at wholesale prices for both medical and recreational use. The overall cannabis industry is growing rapidly in the United States, spurred on by the rapid adoption of plant-tolerant legislation in varying degrees of expression throughout the states and the federal Farm Bill legislation that made hemp a deregulated agricultural product. The U.S. cannabis industry alone is expected to reach $30 billion in market value annually by 2025 (https://ibn.fm/XOzkX). All of which portends optimism for the future of ACP’s efforts. For more information, visit the company’s website at www.ACPFarms.com. NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://ibn.fm/ACP

• Report estimates that 24% of all food in the U.S. — 54 million tons — goes to waste destinations
• Company’s natural treatments protect fresh fruit, vegetables from microbial spoilage and foodborne pathogens
• Save Foods products are reducing by 50% on average the rotten fruit at the retail level

According to ReFED, in 2019, 54 million tons of food was wasted in the United States alone (https://ibn.fm/ONc2n). Save Foods (NASDAQ: SVFD) is an agri-food tech company focused on creating solutions to food waste and loss, as well as food safety. “Our food system is radically inefficient,” reports ReFED, a national nonprofit dedicated to ending food loss and waste across the U.S. food system by advancing data-driven solutions. “In 2019, the U.S. let a huge 35% of the 229 million tons of food available go unsold or uneaten. We call this surplus food, and while a very small portion of it is donated to those in need and more is recycled, the vast majority becomes food waste, which goes straight to landfill, incineration, or down the drain, or is simply left in the fields to rot. “Overall, ReFED estimates that 24% of all food in the U.S. — 54 million tons — goes to these waste destinations,” the article continued. “That’s almost 90 billion meals’ worth of food that we’re letting go unsold or uneaten each year, roughly 2% of U.S. GDP. And the impacts of surplus food and food waste on our climate and environment are enormous, since food that is never eaten still requires resources to grow, harvest, transport, cool, cook or otherwise prepare – even when it ends up being disposed of.” ReFED notes that food waste has been recognized as a global issue requiring immediate action, with numerous organizations and countries, including the United Nations, the U.S. government, European Parliament, and global business coalitions such as the Consumer Goods Forum, setting goals and pledging to cut food loss and waste. Save Foods offers the first natural product with potential to actually replace the different chemicals with a maximum residue level used today while also addressing the challenges of both food waste and food safety. The company’s natural treatments protect fresh fruit and vegetables from microbial spoilage and foodborne pathogens that are responsible for decay and can cause foodborne illnesses, while leaving no harmful residues on the produce or in the environment. “Fresh produces treated with our products can already be found in different supermarket chains across the U.S. and Europe where it was reported that Save Foods products are reducing by 50% on average the rotten fruit at the retail level,” the company reports. “With no need for additional steps or special equipment, our products are easy to implement and come in versatile applications suitable to the different stakeholders along the supply chain.” Save Foods is an innovative, dynamic company addressing two of the most significant challenges in the agri-food-tech industry: food waste and loss and food safety. The company is dedicated to delivering integrated solutions for improved safety, freshness and quality, every step of the way from field to fork. Collaborating closely with its customers, Save Foods develops new solutions that benefit the entire supply chain and improve the safety and quality of life of both workers and the consumers alike. SVFD’s initial applications are in post-harvest treatments in fruit and vegetable packing house processing citrus fruits, avocados, pears, bell peppers and mangos. By controlling and preventing pathogen contamination and significantly reducing the use of hazardous chemicals and their residues, Save Foods products not only prolong fresh produce shelf life and reduce food loss and waste, they also ensure a safe, natural and healthy product. For more information, visit the company’s website at www.SaveFoods.co. NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD

• FuelPositive Corp. is a Canadian-based growth-stage company focused on providing commercially viable and sustainable clean energy solutions
• The company’s primary strategy currently is to commercialize its patent-pending IP for the carbon-free production of ammonia for use across a broad spectrum of industries and applications
• Traditional ammonia is a carbon-intense industry that supplies the 200 million metric tonnes consumed primarily by the agricultural sector each year, but its potential green energy uses include a solution with an energy density by volume that is nearly double that of liquid hydrogen
• Ammonia is more easily transportable than hydrogen and its molecular composition of hydrogen atoms makes it potentially convertible for hydrogen gas or renewable electricity
• The International Energy Agency reported this month that renewable energy sources are growing worldwide but are not keeping pace with rising demand, which means carbon-based fuels will need to cover the gap, in turn leading to expectations of record-level CO2 emissions this year
• André Mech named as Strategic Carbon Credit and Emissions Reduction Specialist

A recent report issued by the International Energy Agency (“IEA”) notes that the use of renewable energy sources is rising worldwide, but not fast enough to meet a strong rebound in global electricity demand this year as national economies begin to recover from the unexpected devastation of the COVID-19 pandemic. That portends a potential sharp rise in the use of polluting coal power for electricity generation (https://ibn.fm/fcdEU). Renewables such as hydropower, wind and solar photovoltaic technology are on track to grow over the next two years by 8 per cent in 2021 and by more than 6 per cent in 2022, but despite the strong growth they will only be able to meet around half the projected increase in global electricity demand, which will leave fossil fuel-based electricity generation to cover 45 per cent of additional demand in 2021 and 40 per cent in 2022, with nuclear power accounting for the rest (https://ibn.fm/OWmT7). Clean energy solutions innovator FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) has made its mission the development of manufacturing, licensing, partnership and acquisition opportunities that build on energy-efficient technologies, and in a July 15 webinar CEO Ian Clifford addressed questions about the company’s patent-pending first-of-its-kind carbon-free ammonia (“NH3”) technology that FuelPositive is working to commercialize as a more efficient alternative to existing “sustainability” efforts. “The environmental imperative for scalable and economically viable replacements for fossil fuel and other highly polluting materials has never been more important, certainly not in my lifetime,” Clifford said in the June investor presentation (https://ibn.fm/ujM7a), reflecting a rising sense of global urgency for using energy in a sustainable way that doesn’t compromise the needs of future generations for the sake of current conveniences — a concern intensified by increasing reports of climate change worldwide. Note: A recording of the webinar is available on the company’s website (https://share.hsforms.com/1bO66RLJhSDeg8kbX9nh7bg4h2fj) https://fuelpositive.com According to the IEA report, the inability of renewable energy sources to keep pace with current demand portends an increase of 3.5 per cent in 2021 and by 2.5 per cent in 2022 of CO2 emissions from the electricity sector globally, resulting in an all-time high output of those emissions next year. FuelPositive’s excitement about the potential of ammonia, also known as hydrogen nitride, is in part because the compound comprising one nitrogen atom bonded to three hydrogen atoms has an energy density by volume that is nearly double that of liquid hydrogen — a more commonly pursued green energy fuel — and it is easier to ship and distribute (https://ibn.fm/aBSfZ). Ammonia production is already a multi-billion-dollar industry, primarily to supply agricultural needs, but FuelPositive’s solution would improve production methods at an affordable, modular and commercial scale to eliminate the need for “dirty ammonia.” “It’s an entirely carbon-intense industry,” Clifford said. “In fact, I just read a really interesting report of one large ammonia refining facility in the Southern states that is interested in converting to green ammonia, but they don’t have any source of green electricity or sustainable electricity so they’re going to have to end up buying carbon credits to offset their energy consumption to produce green ammonia. … Sometimes the producers of the technology aren’t looking at the overall impact of what they’re doing and we believe that’s a very, very important part of the equation and something that we’re focused on heavily as we move forward.” Clifford said the successful commercialization of the company’s IP involves a strategy to manufacture FuelPositive’s Phase 2 Hydrogen-Ammonia Synthesizer commercial prototype systems through an agreement with National Compressed Air Canada Ltd. to roll out the first demonstration systems early next year (https://ibn.fm/i8n0h), eventually leading to revenues from end user purchases and licensing. FuelPositive’s recent announcement that experienced industry adviser André Mech has been named its Strategic Carbon Credit and Emissions Reduction Specialist establishes its leadership for the strategy (https://ibn.fm/5gDkD). “We’re exploring many different ways of going to market, and we will refine that strategy in the coming months,” Clifford said. “It’s really important to us to become a thought leader in this space and to make sure that our message, our values, our solutions are well known at the top of the knowledge chain as it relates to carbon-free ammonia and of course a carbon-free society. … It’s a complex message but I think when it’s simplified down to the core elements, it’s actually a very easy-to-understand solution and we want people around the world to really understand the viability of this and its potential profound effect on positive environmental change.” For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• The company’s FY 2021 numbers show record revenue of $46 million, a 20% year-over-year increase
• WTER issues guidance for the full FY 2022 of $62 million, which would represent year-over-year growth of 35%
• In addition to significant financial highlights, the FY 2021 report noted key operational milestones

As The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER) continues its focus on consistent growth and expansion, its financial reports are tangible proof of the success of those efforts. The company’s FY 2021 numbers show record revenue of $46 million, a 20% year-over-year increase for the country’s largest independent alkaline water company (https://ibn.fm/eQxLz). “Fiscal 2021 was another record year for The Alkaline Water Company continuing our streak of never having a down or a flat year,” said company president and CEO Richard A. Wright. “Our employees and business partners rose to the occasion throughout last year, and we have seen significant sales acceleration into fiscal 2022. We delivered to our customers and consumers when they needed us most. “The trust and appreciation we earned from our strong performance throughout the pandemic allowed us to continue to see more organic and new-store growth, and an expanding presence in more key channels,” Wright continued. “Our guidance for the full fiscal year 2022 is $62 million, which would represent year-over-year growth of 35%.” In addition to the $46 million record revenue, WTER’s financial report for the period ending March 31, 2021, included compound annual growth rate (“CAGR”) of 52% for revenue since fiscal 2015; cost of Goods sold equal to an estimated $29.6 million, which represents a 17% increase over FY 2020; gross profit of some $16.4 million, a 25% increase over the $13.1 million reported in fiscal 2020. In addition, the company reported cash or cash equivalents of more than $9 million. In addition to financial highlights, the FY 2021 report noted key operational milestones, including the fact that the company’s flagship product, Alkaline88(R) water, is now available in more than 75,000 stores across the country. The company also launched its Direct Store Delivery (“DSD”) strategy with Mahaska, Nevada Beverage Company and Hensley Beverage, which combined serve 16,000 clients in five states. WTER also noted significant expansion efforts, including its first move across borders through its international distribution agreement with Mexico-based Tiendas Sindicales, which sells to approximately 6 million customers a month in the Mexican Free Trade Zone. The company also expanded into the multibillion-dollar hospitality and food-service channel through key partnerships with Dot Foods Inc., the largest food redistributor in the United States, and Independent Broker Alliance (IBA Foodservice), an alliance of 30 independently owned and operated foodservice sales agencies. “During Fiscal 2021, we tightened our supply lines, met production demands and added talented employees to our mix,” Wright states. “While the hospitality industry as a whole was disrupted last year, we made significant strides to position ourselves well for channel penetration. We partnered with the largest food redistribution company in the U.S., Dot Foods, and national broker IBA Foodservice. We expect these partnerships to bear fruit in fiscal 2022 as the hospitality industry opens up and on-premise consumption makes a significant comeback. Wright also noted that WTER received new export certificates from the FDA and now have three co-packers that are certified to export. “We expanded into our first international market, with Tiendas Sindicales in Mexico,” he said. “We’re excited for what this means for The Alkaline Water Company, as Mexico has one of the highest per capita bottled water consumption rates in the world. Expansion into the Caribbean and Puerto Rico is already underway in fiscal 2022, and we are confident that Canada can be our next international market.” Looking forward, the company expects to deliver revenue of $62 million, with an estimated gross profit of approximately $23.5 million, according to WTER chief financial officer David Guarino. “This represents revenue growth of approximately 35% for the full year. We expect our top line to be driven primarily by the momentum we’re carrying forward from a successful 2021, which has resulted in SKU expansion, a gain in traction for our single-serves, and significant organic growth within our existing retail clients. This momentum should also allow us to see expanded distribution to additional retailers throughout the country.” For more information, visit the company’s website at www.TheAlkalineWaterCo.com and www.a88CBD.com. NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

• Infobird continues to invest in AI resources, research, and development to provide its customers with SaaS products that come integrated with AI capabilities
• It plans to capitalize on the growing AI wave and an industry that is projected to grow to US$24.6 billion by 2025
• Infobird plans to capitalize on its understanding of AI, its big data technology, and its brand equity to grow its market share and penetrate various industries within the Chinese market
• Its primary focus currently is on intelligent quality inspection, a system of RPA based on big data for intelligent and automatic quality inspection of customer service

The popularity of Artificial Intelligence (“AI”) is growing. Its influence on processes and business cannot be ignored. Back in 2019, the retail automation market was valued at US$12.45 billion and is expected to grow to US$24.6 billion by 2025 (https://ibn.fm/E4lIR). This growth will largely be fueled by the growing development in natural language processing and the monetary incentives that this automation offers. Infobird (NASDAQ: IFBD) has made incredible strides in its natural language processing technology and understanding of the market. It plans on capitalizing on these strides and the ongoing AI wave to differentiate itself from its competitors and offer value to its clients. Infobird is currently at the forefront of pushing for intelligent quality inspection. This is a system of robotic process automation (“RPA”) based on big data, AI, and other technologies that allow big enterprises to achieve intelligent and automatic quality inspection of customer service. This is a track of the whole intelligent product that can automatically keep engagement between companies and their client. The business value based on this is large. It can not only ensure higher policy or business compliance, but also empower the management team to better standardize the services they provide to the clients, which is key to large customer service or sales centers. In addition to these technologies, the company is committed to customizing exclusive models for particular fields to maximize the recognition effect, thereby proving more beneficial to customers. Infobird is a software-as-a-service (“SaaS”) provider of AI-powered customer engagement solutions specifically for the Chinese market. With its self-developed cloud computing structure, machine learning, AI, and patented Voice Over Internet Protocol (VoIP) application technologies, the company has appealed to its customers a lot more and offered a unique value proposition that not many other companies present in the market today (https://ibn.fm/iTJcj). Infobird’s foundations are on technology, hence its commitment to AI. The company also has 70 Intellectual Property (“IP”) rights developed under its cloud-native architecture and AI technologies. Since it was founded in 2001, it has been committed to improving its services and leveraging technology. Initially, the company joined the call center industry, primarily as a middleware manufacturer. However, following years of technical accumulation, it is now able to offer AI-powered call centers and was able to bring in revenues of over US$14.5 million back in 2020 (https://ibn.fm/HBLlt). The Chinese SaaS industry is growing at a tremendous pace, posting an increase in value from US$33 billion back in 2019 to US$47 billion in 2020. In 2022, it is expected to be valued at US$69 billion (https://ibn.fm/W2qRT). Infobird plans on making the most out of this market and capitalizing on its growth. Its years of experience, innovations, and achievements so far position it as an industry leader. Also, given its understanding of AI, its big data technology, and its brand equity, the company is projected to grow and even penetrate further into other sectors that include but are not limited to public services, education, healthcare, transportation, and retail sectors. Infobird’s investment in AI resources, research, and development allows it to provide its customers with SaaS products that come integrated with AI capabilities. The company fully understands the value and potential of AI, hence its commitment to invest in its products and services and continue innovating to best help small and medium-sized enterprises in China. For more information, visit the company’s website at www.Infobird.com/en/index.html. NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD

• The pay-per-view match was streamed on Showtime as well as several forms of post-fight media including ESPN, Sky Sports and Barstool
• TryTAAT landing page received new visitors from more than 30 different countries
• TAAT logo displayed to millions of global viewers who watched the match, as well as post-fight coverage

Interest in TAAT(TM), the nicotine-free and tobacco-free smoking product offered by TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) has risen sharply following the company’s sponsorship of the June 6, 2021, boxing match between world champion boxer Floy Mayweather and internet personality Logan Paul. The pay-per-view match, was streamed on Showtime as well as several forms of post-fight media including ESPN, Sky Sports and Barstool. The weekend of the fight, the company’s TryTAAT landing page received new visitors from approximately 30 different countries (https://ibn.fm/uup0R). More than 14% of those who visited the page, which offers a complimentary pack of TAAT Original, Smooth, or Menthol requested a sample, with the total number of sample requests for the weekend reaching as much as 15.5 times higher than weekends in May 2021. The company also reported additional interest on Instagram, where the TAATGlobal and TryTAAT channels combined saw a 200% increase in followings. Although total numbers of those who viewed the fight and after-fight media hasn’t been released, TAAT reported that its logo was displayed to millions of global viewers who watched the match, as well as post-fight coverage. TAAT’s sponsorship called for between six and eight of Mayweather’s entourage personnel to wear a baseball hat with the TAAT logo clearly visible during their entry to the arena and approach towards the boxing ring (https://ibn.fm/JTYNG). In addition, Mayweather posted a video introducing TAAT on his Instagram profile in both timeline and story posts; Mayweather has 26.3 million followers. Paul also posted footage from the match, and that footage shows the TAAT as well; Pauls has 20.1 million followers on his Instagram account. “As an athlete, naturally, I avoid anything that limits my ability to perform, so I can’t speak for smokers,” said Mayweather about the sponsorship. “But any addictive product that impacts the lungs is going to limit your ability to be the best version of you. I don’t judge you for your decision to smoke, but don’t claim to be the best version of yourself when you turn to nicotine and addictive substances over healthy alternatives.” TAAT Global Alternatives has developed TAAT, a tobacco-free and nicotine-free alternative to traditional cigarettes available in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco, a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched first in the United States in Q4 2020 as the company seeks to position itself in the $814 billion global tobacco industry. For more information, visit the company’s websites at www.TryTAAT.com and www.TAATGlobal.com. NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

• Delta-8 THC among many new strains gaining popularity with consumers in rapidly growing cannabis market
• Studies suggest optimized cannabinoid profiles play role in efficacy, strains can be optimized for recreational and medical uses
• Pac Roots leverages genetics-first approach to produce superior strains with optimized cannabinoid profiles, resistance to fungus, maximum yields

With promises of pain relief, minimal paranoia and a milder euphoric effect, Delta-8 THC is emerging as a gentler alternative to traditional marijuana that is high in Delta-9 THC – the psychoactive component found in conventional cannabis (https://ibn.fm/oABXj). Through its genetics-first cultivation approach, Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), a Canadian cannabis company that leverages the power of genetic technology, is positioned favorably to capture a significant portion of the rapidly growing demand for premium cannabis products. Strains with high concentrations of Delta-8 THC are among many new varieties of cannabis entering mainstream consumer consciousness. With varying degrees of potency, numerous textures, and distinct flavors, these emerging product lines are leveraging consumer demand for novel strains that can be used for different purposes. While still in a legal grey area, industry experts such as New Leaf Data Services CFO Ian Laird have recognized Delta-8’s potential, dubbing it as “the fastest growing segment” of hemp strains that have “really come out of nowhere over the past year.” In accordance with the growing demand for specialized products, Pac Roots produces distinctive cannabis strains tailored for a variety of medical and recreational purposes through its exclusive partnership with Phenome One – a plant breeding management and analytics firm. The agreement sets Pac Roots apart from other producers by giving the Company access to one of Canada’s largest live genetic libraries. Comprised of over 350 unique laboratory-verified and stringently field-tested cannabis cultivars, the catalog also contains over 50 “super-elite” strains prized in the industry. Besides the ability to optimize cannabinoid profiles, Pac Roots’ partnership with Phenome One also allows the Company to produce first-in-class fungus-resistant strains that provide maximum yields – and profits. Optimizing cannabis strains is verified science, according to recent research reports that outline how varying amounts of specific cannabinoids and other active cannabis compounds provide superior pain relief and increased control of epileptic seizures (https://ibn.fm/U6ijs). Referred to as the “entourage effect”, researchers attribute the remarkable performance of optimized cannabis to the synergistic effect of specific cannabinoids and other organic compounds found in the plant. As the popularity of distinctive strains like Delta-8 continue to gain momentum, the need for specialized cannabis cultivation is expected to grow. With access to Phenome One’s exclusive genetic library, Pac Roots is favorably positioned to address this growing market as a leader in genetics-focused cannabis cultivation. For more information, visit the company’s website at www.PacRoots.ca. NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://ibn.fm/PACR

• TAAT offers tobacco-free, nicotine-free experience that goes beyond smoking
• Exclusive product touches all-important five sensory elements of smoking
• Company is gaining TAAT gaining momentum in the $814 billion tobacco industry”

In a world where tobacco and nicotine use both cause concerns, TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) is looking to offer alternatives to smokers that move beyond tobacco yet still offer smokers the satisfaction that comes from the smoking experience. TAAT has developed TAAT(TM), a tobacco-free and nicotine-free option that is capturing a lot of attention in the smoking world. “Available in three flavors (Original, Menthol and Smooth), the tobacco-free, nicotine-free product is made from an exclusive Beyond Tobacco(TM) base material,” a recent TAAT article explains (https://ibn.fm/3eyKy). “The material undergoes a 14-step process, including a patent-pending refinement step, which results in a substance that tastes, smells and smokes just like tobacco. “By creating this experience that goes beyond smoking, TAAT touches the all-important five sensory elements of smoking a tobacco cigarette,” the article continues. “This includes nearly identical packaging and smoke volume (visual), crackling sound upon lighting (auditory), a tobacco-like scent while burning (smell), and ‘hand-to-mouth’ motor habits (touch). Ashes can even be ‘flicked’ in a similar manner to tobacco ashes.” In short, the article concludes, “TAAT’s Beyond Tobacco base material even offers a tobacco-like taste — all without using an iota of nicotine or tobacco. Not only is the TAAT smoking experience identical on every sensory level, it has a practical appeal too. A pack of TAAT is priced at $3.99 in Ohio, approximately 43% less than a pack of Marlboro, which costs about $7.00 per pack.” TAAT is a relatively newcomer to the smoking industry, yet it is garnering a huge amount of attention. In rapid succession, the company initially unveiled the product on the ground in a launch focused in Ohio; launched a website and offered sample packs; increased production to meet growing demand; expanded into Canada and the United Kingdom; uplisted to the OTCQX exchange; and increased the size of its facilities by more than 250% — and that wasn’t all. TAAT CEO Setti Coscarella called out additional milestones when he commented on a profile article appearing in “Forbes” magazine (https://ibn.fm/VFQSV). “After approximately six months as the CEO of TAAT, it is very fulfilling to see so many things falling into place,” said TAAT CEO Setti Coscarella. “In 2021 alone, we have had impressive sell-out and reorder rates of TAAT, submitted international trademark applications in over 50 countries, launched a statewide digital out-of-home promotional campaign in Ohio, and finalized our partnership with a prestigious CPG sales agency that directly services more than 100,000 convenience stores in the United States. Obtaining coverage of TAAT in a national mainstream news outlet such as Forbes is also a tremendous milestone, because it demonstrates positive reception and validation of TAAT as a company that is gaining momentum in the USD$814 billion tobacco industry.” Looking forward, the company anticipates continued growth and success. This month, TAAT entered a sponsorship high-profile sponsorship arrangement with world champion boxer Floyd Mayweather and his ringside entourage for Mayweather’s highly anticipated boxing match against Logan Paul on Sunday, June 6, 2021, at the Hard Rock Stadium in Miami, Florida. The company is always looking for additional opportunities to increase awareness of its unique and exclusive product. TAAT Global Alternatives has developed TAAT, a tobacco-free and nicotine-free alternative to traditional cigarettes available in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco, a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched first in the United States in Q4 2020 as the company seeks to position itself in the $814 billion global tobacco industry. For more information, visit the company’s websites at www.TryTAAT.com and www.TAATGlobal.com. NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF